News

H5N1 bird flu can cause severe illness in humans. Experts warn it spreads from animals, not people, but can turn deadly if ...
H5N1, or bird flu, initially presents with common flu-like symptoms such as fever, cough, and fatigue, making early detection ...
India has over 2,500 political parties — Prime Minister Modi shocks Ghana's Parl ...
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.
Relative to before the pandemic, the number of vaccinated participants fell 10% among children and 4% in adults in pandemic ...
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
A 36-year-old woman, admitted to intensive care, is the latest in a string of new infections in the last 10 days ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...